1 Beyond diabetes and obesity Cardiovascular disease In March 2024, the US Food and Drug Administration (FDA) approved Wegovy (semaglutide) for adults with cardiovascular disease (CVD) and either obesity and overweight to reduce the risk of cardiovascular death, heart attack, and stroke
Our most popular weight loss treatment is GLP-1 medication, however we offer a variety of alternative treatments, including Peptide Therapy
Novo Nordisk, the manufacturer of Ozempic and Wegovy, provided the following statement to the BBC
Its a wonderful option for those looking to reclaim their intimate health and feel more like themselves again
Youre gaining weight around your midsection despite eating the Read More Signs of Low Testosterone Video Transcription Dr
Glutathione IV therapy is generally safe when administered by a professional